Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00214630 · ClinicalTrials.gov registry record · Phase 3
LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary Syndromes
A Phase 3 study, sponsored by AstraZeneca.
- Completed
- Registry status
- Phase 3
- Development phase
- 825
- Enrollment target
NCT00214630: Completed Phase 3 study, sponsored by AstraZeneca.
NCT00214630 is a Phase 3 study that has completed, run by AstraZeneca. The registered enrollment target is 825 participants, roughly in line with the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00214630, a Phase 3 study, has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 825 participants
- Enrollment target
Study Summary
Comparison of rosuvastatin and atorvastatin in subjects with acute coronary syndromes
Interventions
- DRUG atorvastatin
- DRUG rosuvastatin calcium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 825 participants |
| Start Date | 2003-12 |
| Est. Completion | 2007-08 |
| Phase | Phase 3 |
What the finished NCT00214630 record still lists
NCT00214630 is an interventional study that assigns participants to a tested intervention. The registered 825 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which atorvastatin is the first listed.
NCT00214630 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00214630 about?
NCT00214630 is a clinical study titled "LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary Syndromes". Comparison of rosuvastatin and atorvastatin in subjects with acute coronary syndromes
What is the current status of trial NCT00214630?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 825 participants. The study started on 2003-12. Estimated completion is 2007-08.
What interventions are being tested in trial NCT00214630?
The interventions under investigation include: atorvastatin (DRUG), rosuvastatin calcium (DRUG).
Who is sponsoring clinical trial NCT00214630?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00214630's enrollment target sits among peer trials
825 400th of 2000 higher than 1,599 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05630482 · 825 participants · NA
Randomized Trial of Healthy Family Foundations
- NCT06097728 · 825 participants · Phase 3
MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma
- NCT07102641 · 825 participants · Phase 4
Post-cesarean Analgesia: Comparing Effectiveness of Staggered v. Simultaneous Therapies
- NCT07318077 · 825 participants · NA
Radicle GI Health DBG: A Study Assessing the Impact of Health and Wellness Products on GI Health and Related Health Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia